Rx/Reimbursement Adult Incontinence in Colombia

April 2026

In 2025, rx/reimbursement adult incontinence in Colombia experienced positive growth, with volume reaching 196 million units, a year-on-year increase of 3% compared to the previous year. This growth follows a recovery from a steep decline in 2024 and is supported by a 9% increase in manufacturer selling price value to COP392 billion. The underlying driver of this performance is the ongoing reliance on the public health system, where EPS (Entidades Promotoras de Salud) dispenses these products th

USD 1,195
Request More Information

Delivery:

Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).

This report comes in PDF with additional info in Excel included.

Overview:

Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Colombia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.

Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.

If you're in the Rx/Reimbursement adult incontinence industry in Colombia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.

The Rx/Reimbursement adult incontinence in Colombia report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volume and value sizes, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent research methodology, conducted in-country

This report answers:

  • What is the market size of Rx/Reimbursement adult incontinence in Colombia?
  • Which are the leading brands in Rx/Reimbursement adult incontinence in Colombia?
  • How are products distributed in Rx/Reimbursement adult incontinence in Colombia?
  • How is the rise of e-commerce changing the retail and competitive landscape?
  • How has COVID-19 impacted demand? Where have sales increased due to stockpiling amidst national lockdown?
  • How have enforced home seclusion and social distancing measures following COVID-19 changed usage patterns for Rx/Reimbursement adult incontinence products?
  • Where is future growth expected to be most dynamic?
  • How important will sustainability and recycling be in generating future growth?

Rx/Reimbursement Adult Incontinence in Colombia - Category analysis

Key Data Insights

Public System Reliance Spurs Post-Decline Expansion
Chart 1 Key Industry Trends for Rx/Reimbursement Adult Incontinence
Public System Reliance Spurs Post-Decline Expansion
Chart 2 Value Sales 2020-2030
Chart 3 Volume Sales 2020-2030
Delayed Health Funding Restricts Access to Prescribed Incontinence Supplies
Chart 4 Forecast Value Sales 2020-2030
Eps Centralises Supply by Awarding Public Tenders to Cost-Competitive Suppliers
Chart 5 Economic Context for Rx/Reimbursement Adult Incontinence
Chart 6 Real Gdp Growth 2020-2030
Chart 7 Inflation 2020-2030
Chart 8 Consumer Context for Rx/Reimbursement Adult Incontinence
Chart 9 Population 2020-2030
Chart 10 Consumer Expenditure 2020-2030
Chart 11 Population by Generation 2025

Tissue and Hygiene in Colombia - Industry Overview

Affordability Trend Drives Value-Based Demand as Consumers Shift Spending

Key Data Insights

Chart 12 Key Industry Trends for Tissue and Hygiene
Affordability Trend Drives Value-Based Demand as Consumers Shift Spending
Chart 13 Discounters Offer Premium Products at Affordable Prices
Premiumisation Trend Builds as Consumers Demand Enhanced Features
Chart 14 New improvements to Familia
Huggies Dermacare Elevates Skin Health and Product Innovation for Families
Chart 15 Huggies Dermacare Diapers
Chart 16 Value Sales 2020-2030
Chart 17 Value Sales by Category 2025
Private Label Upgrades Products and Commercial Brands Intensify Innovation
Ageing Demographic to Accelerate Growth for Convenient and Discreet Formats
Eco Claims in Disposable Products Gain Traction While Reusable Products Remain Niche
Chart 18 Analyst Insight for Tissue and Hygiene
Chart 19 Forecast Value Sales 2020-2030
Chart 20 Forecast Value Sales by Category 2025-2030
Essity and Tecnoquímicas Defend Share as Private Label Competition Intensifies
Chart 21 Company Shares 2025
Chart 22 Brand Shares 2025
Discounters Capture Household Spending as Private Label Widens Appeal
E-Commerce Expands Reach via Pharmacy Apps and Rapid Delivery
Chart 23 Retail Channels 2020-2025
Chart 24 Economic Context for Tissue and Hygiene
Chart 25 Real Gdp Growth 2020-2030
Chart 26 Inflation 2020-2030
Chart 27 Consumer Context for Tissue and Hygiene
Chart 28 Population 2020-2030
Chart 29 Consumer Expenditure 2020-2030
Chart 30 Population by Generation 2025

Country Reports Disclaimer

Rx/Reimbursement adult incontinence

To qualify for reimbursement, typically a note from a physician is required (a “prescription”) indicating that the patient is in need of incontinence supplies. Depending on the local system in place, supplies are then either shipped directly to consumer home by a designated service or a consumer has to pick up products at a pharmacy. Please be advised that services and routes to consumers can vary even within the same country and vary by state/region. Some countries provide reimbursement through income tax deductions. If this is the case in your market, we EXCLUDE this type of reimbursement from our Rx/Reimbursement coverage as it would be impossible to track. Additionally, consumers would have already purchased the products in retail before claiming tax deductions, and as such the products have already been counted as retail sales. The same logic applies to institutional sales. If a nursing home purchased adult incontinence products from a distributor/manufacturer for distribution to its patients/residents, these products would be included as AFH adult incontinence in our coverage, even though sometimes patients might claim healthcare deductions for costs of stay at a nursing home.

See all of our definitions
Share:

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.

NEW REPORT GUARANTEE

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!